Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption
T. Bhatt, S. U. Khedkar, B. Dam, S. Lall, S. Pandey, S. Kataria, P. M. Dias, M. Waskar, J. Raut, V. Sundaramurthy, P. K. Vemula, N. Ghatlia, A. Majumdar, C. Jamora
This study shows niacinamide enhances LL37's ability to disrupt SARS-CoV-2 membranes, suggesting it could improve AMP-based therapies for COVID-19.
bioRxiv · Aug 26, 2022Pathology